U.S., April 9 -- An application to own the trademark for 'OPTIDRAIN' has been filed on Feb. 20, 2025.
Owner(s):
Rising Pharma Holdings, Inc.; 2 Tower Center Boulevard, Suite 1401A, New Jersey
Goods and/or Services:
For: Ophthalmic pharmaceuticals, namely, eye drops, solutions, gels, and ointments used for the treatment of eye conditions, including dry eyes, allergies, infection, inflammation, redness and corneal swelling.
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-04-08&serialNumber=99049671
Disclaimer: Curated by HT Syndication....